Ascend Wellness Holdings (AAWH) Common Equity (2020 - 2026)

Ascend Wellness Holdings' (AAWH) quarterly Common Equity came in at -$76.6 million in Q1 2026, down 245.33% year-on-year from $52.7 million in Q1 2025, and down 64.3% quarter-over-quarter from -$46.6 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Common Equity (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Common Equity history runs 7 years deep, the most recent figure standing at -$76.6 million for Q1 2026.

  • On a quarterly basis, Common Equity fell 245.33% year-over-year to -$76.6 million in Q1 2026; TTM through Mar 2026 was -$76.6 million, a 245.33% decrease from a year earlier, with the FY2025 full-year figure at -$46.6 million, down 164.93% from the prior year.
  • Common Equity declined to -$76.6 million in Q1 2026 per AAWH's latest filing, from -$46.6 million in the prior quarter.
  • Across five years, Common Equity topped out at $186.6 million in Q2 2022 and bottomed at -$76.6 million in Q1 2026.
  • The 5-year median for Common Equity is $135.8 million (2024), against an average of $98.8 million.
  • Across the five-year window, Common Equity jumped 1188.41% in 2022 and tumbled 245.33% in 2026, its largest moves.
  • Year by year, Common Equity stood at $163.4 million in 2022, then decreased by 12.57% to $142.9 million in 2023, then plunged by 49.74% to $71.8 million in 2024, then slumped by 164.93% to -$46.6 million in 2025, then sank by 64.3% to -$76.6 million in 2026.
  • Per Business Quant, the three latest AAWH Common Equity figures stand at -$76.6 million (Q1 2026), -$46.6 million (Q4 2025), and $8.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 21.93 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 8.23 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 3.23 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 47.38 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 5.90 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 56.13 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 14.66 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 3.41 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 6.50 Bn
10 Ascend Wellness Holdings 83.00 Mn 22.91 Mn 44.88 Mn -76.59 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -76.59 Mn
Dec 31, 2025 -46.62 Mn
Sep 30, 2025 8.08 Mn
Jun 30, 2025 28.15 Mn
Mar 31, 2025 52.70 Mn
Dec 31, 2024 71.80 Mn
Sep 30, 2024 88.91 Mn
Jun 30, 2024 117.54 Mn
Mar 31, 2024 135.83 Mn
Dec 31, 2023 142.87 Mn
Sep 30, 2023 159.47 Mn
Jun 30, 2023 165.96 Mn
Mar 31, 2023 148.96 Mn
Dec 31, 2022 163.42 Mn
Sep 30, 2022 174.07 Mn
Jun 30, 2022 186.62 Mn
Mar 31, 2022 158.03 Mn
Dec 31, 2021 176.48 Mn
Sep 30, 2021 184.04 Mn
Jun 30, 2021 189.32 Mn